Lipid nanoparticles for precision nucleic acid delivery: linking cellular engineering to organ-specific targeting.
Lipid nanoparticles (LNPs) represent clinically validated non-viral platforms for nucleic acid delivery, yet expanding their application toward precision gene therapy demands more than efficient particle formulation or tissue accumulation. Functional delivery requires navigating a sequential biological cascade: establi...